scholarly journals Pemberdayaan pada Penderita Diabetes Tipe 2 dan Kader Kesehatan dalam Pelaksanaan Program Pos Binaan Terpadu Penyakit Tidak Menular (Posbindu PTM)

2020 ◽  
Vol 4 (1) ◽  
pp. 201-211
Author(s):  
Arief Andriyanto ◽  
Etty Rekawati ◽  
Dwi Cahya Rahmadiyah

Diabetes mellitus is classified as a non-communicable disease which has been estimated to have increased, so a risk factor control program recommended by the Ministry of Health is required according to the DM management pillar. Health cadre empowerment is also needed to actively support non-communicable diseases programs. The purpose of this community empowerment was to change the behaviour of people with type 2 diabetes in glucose control and improve the health cadres' skills in Posbindu PTM activities. The program was carried out in October 2018 until March 2019. The targets were: 86 type 2 diabetes patients, 24 cadres in Cisalak Pasar Kelurahan, 120 cadres in Cimanggis District, and 293 cadres in Depok City. The results showed that patients could control their glucose and health cadres experienced improved skills. The role of community nurses is continuously needed to provide appropriate interventions to the patients.

2019 ◽  
Vol 21 (5) ◽  
Author(s):  
Caroline Holm Nørgaard ◽  
Mitra Mosslemi ◽  
Christina J.-Y. Lee ◽  
Christian Torp-Pedersen ◽  
Nathan D. Wong

2010 ◽  
Vol 16 (1) ◽  
pp. 93-103 ◽  
Author(s):  
M. V. Tsvetkova ◽  
V. N. Khirmanov ◽  
N. N. Zybina

The paper reviews publications concerned the role of nonesterifi ed fatty acids (NEFA) in pathogenesis of cardiovascular diseases. NEFAs are four and more carbons chain length carbonic acids and they are presented in free form (nonesterifi ed) in human body. Plasma NEFAs are produced by the adipose tissue triglyceride lipolysis, another source are lipoproteins such as chylomicrons, very low density lipoproteins and intermediate density lipoproteins. Elevated NEFA concentrations in plasma are the risk factor of cardiovascular diseases and type 2 diabetes mellitus and the independent risk factor of hypertension and sudden death. NEFA plasma concentration is elevated in atherosclerosis, acute myocardial infarction, diabetes mellitus, obesity, hypertension, and often in metabolic syndrome. A probable cause of NEFAs accumulation in plasma may be overeating and low physical activity, which result in increase of adipose tissue mass, lipolysis intensifi cation and elevation of NEFAs concentration in plasma. The role of elevated plasma NEFA concentration in a number of conditions (abdominal obesity, atherogenic dyslipidemia, insulin resistance, type 2 diabetes mellitus, endothelial dysfunction, vascular infl ammation, atherosclerosis, hypertension, ischemic heart disease, rhythm disturbances, sudden death) and possible ways of their correction are discussed.


Author(s):  
Kaushal Kumar Sinha ◽  
Abhishek Bhadani ◽  
Anand Dev ◽  
Abhay Kumar ◽  
Nistha Kishore

Background: Diabetes is one of the commonest chronic non communicable disease affecting the society at large both in developing and developed countries. In our country, as diabetes is diagnosed late, many patients comes with complication of diabetes.  Present study aimed to study the prevalence of neuropathy complications in newly diagnosed type 2 diabetes mellitus. Subjects and Methods: In this study, 100 newly diagnosed cases of type 2 diabetes mellitus patients were evaluated. A cross section of both male and female diabetes patients diagnosed within the last 3 months (new onset) was taken into study. A detailed history, clinical examination and relevant investigations were performed. Collected data were analysed by using appropriate software. Results: In our study 60% were male and 40% were female. Highest neuropathy complication was seen in 56-65 age group. It was present in 35% of female and 16.66% of male in our study. Conclusion: Endeavour should be made to control hyperglycemia and dyslipidemia tightly by appropriate therapeutic measures so that the occurrence and worsening of complications could be mitigated. Aims and Objectives: To study the Prevalence of neuropathy complication in newly diagnosed type 2 diabetes mellitus


2021 ◽  
Vol 12 (1) ◽  
pp. 7-13
Author(s):  
Charu Bansal ◽  
Rachna Jain ◽  
Umesh Shukla ◽  
Smita Paul

India is recognized as diabetic capital of the world now and among all chronic diseases increased prevalence of Type 2 Diabetes mellitus has been recognized globally. Though various modifiable risk factors are identified for the development of type 2 diabetes mellitus such as prediabetes, overweight, obesity, poor diet, smoking, physical inactivity and given importance in the management of disease. But among all stress and anxiety has not been getting proper importance in development and management of Type 2 diabetes. Though number of studies have been identified stress as risk factor for type 2 diabetes. Thus, the present write up is aimed to review the effect of different emotional stressor as risk in the development and uncontrolled hyperglycemia in type 2 diabetes mellitus patients with effective solutions. Material and Methods: This review is based on data collected from classical Ayurvedic literature, and published research works in various journals. Observations and Results: cited based on research reviews to find out risk odds of different emotional stressor and type 2 diabetes with solutions based on Ayurveda and Yoga principles such as role of Raga therapy, Yogasan, Pranayama (breathing technique), Panchakarma procedures and use of Medhya Rasayana (nootropic) drugs. Conclusion: Counselling would be one of the best strategy to create awareness among healthy individual and type 2 diabetic to opt healthy behaviour to manage emotional stress and for the prevention and better control of type 2 diabetes mellitus. Thus, Present write up is an effort to provide attention on various emotional stressor as risk factor and also discuss the various healthy behavioural techniques to control emotional stress.


Author(s):  
Krishna K Patel ◽  
Bernard Charbonnel ◽  
Hungta Chen ◽  
Javier Cid-Rufaza ◽  
Peter Fenici ◽  
...  

Background: Guidelines recommend optimal control of cardiovascular risk factors such as blood pressure, lipids and smoking in addition to glycemic control to reduce the risk of micro and macro-vascular complications in patients with type 2 diabetes mellitus (T2D). However, the extent of comprehensive cardiovascular risk factor control in T2D internationally is not well-known. Methods: A total of 14,169 T2D patients initiating second-line therapy across 37 countries were enrolled in the DISCOVER registry. Optimal cardiovascular risk factor management at study baseline was defined as control of the following risk factors among eligible patients: 1) Systolic BP <140mmHg for all T2D patients; 2) statin prescription in all T2D patients ≥ 40 years, high-intensity statin for those with T2D and ASCVD; 3) non-smoking status for all T2D patients; 4) treatment with ACE-Inhibitor/Angiotensin Receptor Blocker (ACEI/ARB) in patients with T2D and 5) hypertension (HTN)/albuminuria and secondary ASCVD prevention with low-dose aspirin (ASA) in those with T2D and ASCVD. Global and country specific rates of individual and combined risk factor control were calculated. Inter-country variability was estimated using median odds ratios (MOR). Results: Mean age of the DISCOVER cohort was 56.6 (SD= 11.7) years; 7534 (53.2%) were male, mean BMI was 29.6 (SD= 5.9) kg/m 2 , median duration of T2D was 4.1 (IQR 2.0, 7.8) years. A total of 1643 (11.9%) patients had ASCVD, 7221 (51.0%) had HTN and 606 (4.3%) had albuminuria. Overall, among eligible patients, BP was controlled in 67.2% (9043/13457); statin treatment was prescribed in 38.3% (4977/12987); 85.2% (12,075/14169) were not smoking; ACEI/ARB treatment was prescribed in 53.7% (4917/9151), and ASA for secondary prevention was prescribed in 51.6% (847/1643) patients with ASCVD. Of 13,118 patients with 3 or more risk factors, 5312 (40.5%) had optimal control of at least 3 risk factors with wide inter-country variability. Conclusion: In a global registry of individuals with T2D from 37 countries, comprehensive control of ASCVD risk factors was not achieved in most patients, with wide variability among countries. Better strategies are needed to consistently provide comprehensive cardiovascular risk factor control in patients with T2D to improve long term outcomes.


Sign in / Sign up

Export Citation Format

Share Document